These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3682432)

  • 1. Immunohistochemical demonstration of estrogen, progesterone, CEA and ferritin in breast cancer and their clinical value for the prediction of early postoperative recurrence.
    Majima T; Kojima O; Uehara Y; Tokuda H; Kano M; Takahashi T
    Jpn J Surg; 1987 Jul; 17(4):243-7. PubMed ID: 3682432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen staining in breast carcinoma by PAP methods compared to CEA and ferritin staining.
    Osamu K; Takashi M; Yohichi T; Yasuo U; Tetsuro Y; Yoshiro F; Toshio T
    Cancer Detect Prev; 1987; 10(1-2):113-20. PubMed ID: 2436774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
    Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM
    Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic contributions of Helix pomatia and carcinoembryonic antigen staining using histochemical techniques in breast carcinomas.
    Fukutomi T; Itabashi M; Tsugane S; Yamamoto H; Nanasawa T; Hirota T
    Jpn J Clin Oncol; 1989 Jun; 19(2):127-34. PubMed ID: 2733166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoembryonic antigen, ferritin, and tissue polypeptide antigen in serum and tissue. Relationship with the receptor content in breast carcinoma.
    Gion M; Mione R; Dittadi R; Fasan S; Pallini A; Bruscagnin G
    Cancer; 1986 Mar; 57(5):917-22. PubMed ID: 3943025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tissue CEA as a prognostic factor in advanced and recurrent breast cancers].
    Tsukikawa S; Kubota S; Biwata T; Shimomura T; Ohyama I; Nagashima T; Kanasugi K; Fukuda M; Yamaguchi S; Maruyama Y
    Gan No Rinsho; 1986 Aug; 32(9):961-4. PubMed ID: 3747160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A clinicopathological study on carcinoembryonic antigen in breast cancer].
    Asagoe T; Yamoto H; Hanatani Y; Horie F; Nemoto A; Kidooka K; Shikata J
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):793-8. PubMed ID: 2370434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients.
    Esteban JM; Felder B; Ahn C; Simpson JF; Battifora H; Shively JE
    Cancer; 1994 Sep; 74(5):1575-83. PubMed ID: 7914825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue and plasma carcinoembryonic antigen in early breast cancer. A prognostic factor.
    Mansour EG; Hastert M; Park CH; Koehler KA; Petrelli M
    Cancer; 1983 Apr; 51(7):1243-8. PubMed ID: 6825048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoembryonic antigen. A possible predictor of recurrence in cystosarcoma phyllodes.
    Alberti O; Brentani MM; Goes JC; Lemos LB; Torloni H
    Cancer; 1986 Mar; 57(5):1042-5. PubMed ID: 3002592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of carcinoembryonic antigen in the postmastectomy follow-up of primary breast cancer and in the prognostic evaluation of disseminated breast cancer.
    Palazzo S; Liguori V; Molinari B; Greco LM; Mancini V
    Tumori; 1984 Feb; 70(1):57-9. PubMed ID: 6710608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of CEA and ferritin assay in breast cancer: a multivariate analysis.
    Gaglia P; Caldarola B; Bussone R; Potente F; Lauro D; Jayme A; Caldarola L
    Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1151-5. PubMed ID: 3416899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical value of immunohistochemically demonstrable CEA in breast cancer: a possible method of selecting patients for adjuvant chemotherapy.
    Smith SR; Howell A; Minawa A; Morrison JM
    Br J Cancer; 1982 Nov; 46(5):757-64. PubMed ID: 6756459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and significance of ER, PR, VEGF, CA15-3, CA125 and CEA in judging the prognosis of breast cancer.
    Zhang SJ; Hu Y; Qian HL; Jiao SC; Liu ZF; Tao HT; Han L
    Asian Pac J Cancer Prev; 2013; 14(6):3937-40. PubMed ID: 23886210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of elevated CEA values in the follow-up management of patients with breast cancer].
    Paulick R; Caffier H
    Geburtshilfe Frauenheilkd; 1985 Nov; 45(11):774-9. PubMed ID: 4076751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum carcinoembryonic antigen and prognosis of breast cancer patients postmastectomy.
    Paulick R; Caffier H
    Cancer Detect Prev; 1988; 11(3-6):311-7. PubMed ID: 3390852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoembryonic antigen immunocytochemistry in primary breast cancer.
    Robertson JF; Ellis IO; Bell J; Todd JH; Robins A; Elston CW; Blamey RW
    Cancer; 1989 Oct; 64(8):1638-45. PubMed ID: 2790676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunostaining for carcinoembryonic antigen does not discriminate for early recurrence in breast cancer. The ECOG experience.
    Gilchrist KW; Kalish L; Gould VE; Hirschl S; Imbriglia JE; Levy WM; Patchefsky AS; Pickren J; Roth JA; Schinella RA
    Cancer; 1985 Jul; 56(2):351-5. PubMed ID: 3891068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunohistochemical evaluation of several tumor markers (CEA, ferritin, Ca) and their correlation with estro-progestin receptor state in neoplasms].
    Forti E; Wolf D; Melia M
    Pathologica; 1985; 77(1049):241-9. PubMed ID: 3913892
    [No Abstract]   [Full Text] [Related]  

  • 20. Significance of serum concentrations of carcinoembryonic antigen, ferritin, and calcitonin in breast cancer.
    Bezwoda W; Derman D; Bothwell T; MacPhil P; Levin J; De Moor N
    Cancer; 1981 Oct; 48(7):1623-8. PubMed ID: 7284963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.